Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Clinical Nuclear Medicine|October 18, 2016
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate CancerOladunni O Akin-Akintayo, Ashesh B Jani, Oluwaseun Odewole, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT GuidanceOlayinka A Abiodun-Ojo, Ashesh B Jani, Akinyemi A Akintayo, et al.ESMO Open|July 24, 2026
Platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in metastatic urothelial carcinoma: a real-world studyM Sternschuss, K Whiting, A Arbuiso, et al.European Radiology|November 22, 2011
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancerM J Gollub, D H Gultekin, O Akin, et al.Journal of American College Health : J of ACH|July 11, 2022
Food insecurity among university students in the United States amidst the COVID-19 pandemicHelene Vilme, Naomi N Duke, Yussif Dokurugu, et al.Amino Acids|June 16, 2018
Selective modification of fluciclovine (18F) transport in prostate carcinoma xenograftsF I Tade, W G Wiles, G Lu, et al.Journal of Viral Hepatitis|November 7, 2017
Historical epidemiology of hepatitis C virus in select countries-volume 4A Maaroufi, A Vince, S M Himatt, et al.Journal of Viral Hepatitis|November 7, 2017
Strategies to manage hepatitis C virus infection disease burden-Volume 4D S Chen, W Hamoudi, B Mustapha, et al.Journal of Viral Hepatitis|November 7, 2017
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4H L Y Chan, C J Chen, O Omede, et al.Nature Communications|February 13, 2023
Emergence and spread of two SARS-CoV-2 variants of interest in NigeriaIdowu B Olawoye, Paul E Oluniyi, Judith U Oguzie, et al.Pageof 8